Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 29, 2019

Mikhlin v. Oasmia Pharmaceutical AB et al

Track this case

Case Number:

1:19-cv-04349

Court:

New York Eastern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Nicholas G. Garaufis

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 07, 2021

    Swedish Biotech Oasmia Settles Investor Claims For $2.4M

    A New York federal judge on Wednesday gave preliminary approval to a $2.4 million settlement to end claims from investors that Swedish biotechnology company Oasmia Pharmaceutical AB hid deals it had with two other companies owned by its founder and a former board member.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login